Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer

Bibliographic Details
Title: Alliance A011801 (compassHER2 RD): postneoadjuvant T-DM1 + tucatinib/placebo in patients with residual HER2-positive invasive breast cancer
Authors: O'Sullivan, Ciara C, Ballman, Karla V, McCall, Linda, Kommalapati, Anuhya, Zemla, Tyler, Weiss, Anna, Mitchell, Melissa, Blinder, Victoria, Tung, Nadine M, Irvin, William J, Lee, Myounghee, Goetz, Matthew P, Symmans, William Fraser, Borges, Virginia F, Krop, Ian, Carey, Lisa A, Partridge, Ann H
Source: Future oncology. 17(34):4665-4676
Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100187768848.0x000001&indx=1&recIds=ETOCvdc_100187768848.0x000001
Database: British Library Document Supply Centre Inside Serials & Conference Proceedings
More Details
ISSN:14796694
Published in:Future oncology
Language:English